Fig. 1From: A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participantsDescription of (A) study design and (B) randomization scheme a Participants were also stratified by neuromuscular blocking agent, rocuronium or vecuroniumBack to article page